Cereplast is a startup. There is nothing unusual in these
Cereplast is a startup. There is nothing unusual in these type businesses operating for years without producing a profit. We are on the cusp of simply enormous revenues and we have very real prospects of profitability 2014.
Some here want to talk about anything but the prospects of the company and the stock.
Let's see. . .
1. Catching the wave of first world environmentalism as plastics of one type or another are banned all over Europe and North America.
2. Perfectly positioned for the anti plastic fever that is hitting the second world as they face the very real problems of inadequate waste disposal systems.
3. Rising oil prices that make bio plastics not only competitive but actually cheaper than petroleum based plastics.
4. An existing manufacturing plant in North America that is ramping up production. A facility ideally located in Italy and capable of beginning production in a very short time frame. Plans for a factory in India that were at one time so advanced that the CEO expected Indian production before Italian production.
5. Partnerships and joint ventures in Brazil ready to explode. Brazil is expected to be the largest producer of bio plastics on the globe. That makes four continents on which Cereplast has a footprint.
6. Mr. Scheer - CEO of Cereplast - created the Biodegradable Products Institute (BPI) which sets the industry wide standards for bio plastics. He has worked with the biodegradable industry since 1994. He is the Steve Jobs of bio plastics. A man with a vision who has worked tirelessly for 17 years to create this industry.
7. Three dozen Indian companies working out the details of making a wide range of consumer and industrial products from Cereplast's resins. Once Indian companies begin production, their experience will speed the production of these products in other countries AND create a huge export market outside India for products made from bio plastics.
8. Numerous patents for bio plastic formulas including some very exciting work with industrial algae. I predict that the algae based bio plastics will be much cheaper than corn based plastics and so does Cereplast. It has spun off an entire division devoted to algae based bio plastics.
Industrial algae is the future. At least Solazyme thinks so and guess what, so does Archer Daniels Midland which has given the equivalent of an oil refinery to Solazyme.
Guess where the biggest market is for Solazyme's oils produced from algae. That's right. Brazil. Remember Brazil? Projected to be the biggest producer of bio plastics on the planet?
9. How big is the worldwide market for plastics? One trillion dollars per year. That is the market we are going after. One trillion dollars per year.
Hong Yuan Hldg Group (HGYN) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...
Continue Reading
Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....
Continue Reading
New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...
Continue Reading
The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...
Continue Reading
JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...
Continue Reading
Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...
Continue Reading
Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...
Continue Reading
Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...
Continue Reading
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...
Continue Reading
Top 5 Most Recently Viewed Articles
ICEYE Partners with Finnish Defence Forces for Satellite Technology ICEYE has forged a significant partnership with the Finnish Defence Forces to bolster their intelligence and surveillance capabilities through the acquisition of synthetic aperture radar (SAR) satellites. This strategic agreement marks a major step forward for the Finnish Defence Forces as they seek to...
Continue Reading
Executive Home Care: Pioneering Senior Care Franchises As the U.S. senior population is set to increase significantly in the upcoming decades, the need for quality in-home care services has never been more pressing. With projections indicating that the senior demographic will double by 2050, opportunities within the senior care industry continue to expand. Executive Home...
Continue Reading
Bybit Card Launches Global Crypto Challenge for Travellers Bybit, a prominent name in the cryptocurrency exchange landscape, has unveiled an exciting initiative aimed at avid travelers and cryptocurrency enthusiasts. The launch of the Bybit Card brings a unique opportunity for users to explore their world while earning rewards. This initiative is not just about testing...
Continue Reading
Pan American Energy's Strategic Move Pan American Energy Corp. (CSE: PNRG | OTCQB: PAANF | FRA: SS60) is excited to announce its plans to execute a significant non-brokered private placement financing. This initiative will encompass up to 4,350,000 common shares at a price of C$0.18 per share, potentially generating gross proceeds of $783,000. On top of this, there will...
Continue Reading
Important Developments for EMGS Bondholders Electromagnetic Geoservices ASA, commonly known as EMGS, recently shared significant information with its stakeholders regarding bondholder resolutions. This pertains mainly to the Elec ASA 18/25 FRN USD FLOOR STEP C CONV bonds, referred to as EMGS03. Overview of the Bondholder Resolution In an official statement, EMGS announced...
Continue Reading